Back to RecallTracker
Health Canada Health products

Accupril Tabs: Nitrosamine impurity

Issued April 20, 2022
Issue
Presence of N-Nitroso-quinapril above the acceptable concentration limit in affected lots.
Hazard description
Contamination
What to do
Continue taking your medication unless you have been advised to stop by your health care provider. Not treating your condition may pose a greater health risk. Contact your health care provider to discuss other treatment options. There is currently a reduced supply of combination quinapril hydrochloride and hydrochlorothiazide nationally; however, other drug products are available for treating high blood pressure. If you have questions about the recall, contact Pfizer Canada ULC at 1-800-463-6001 or www.pfizermedinfo.ca for medical inquiries, and at 1-800-387-4974 for general inquiries. Report any health product-related side effects or complaints to Health Canada.
Product
Product name
Accupril Tabs
Reference
ID
RA-64095